| Home |
| Site Map |
| News Archives |
| Environmental Health News |
| Illness Research |
| Articles |
| Treatment Information |
| Useful Lab Tests |
| Find A Doctor |
| Chemical Avoidance |
| Allergen Reduction |
| Water Filtration |
| Treatments & Products |
| Books |
| Water Filters |
| SAD Light Boxes |
| Hepa Air Purifiers |
| HEPA Vacuum Cleaners |
| Nutritional Supplements |
| Home Test Kits |
| Personal Care |
| Cleaning Products |
| LifeWave Patches |
|
|
| Research - Mental and Emotional Problem Research | |
|
J Psychiatr Pract. 2006 Jul;12(4):205-13.
Exercise as an augmentation strategy for treatment of major depression.
Trivedi MH, Greer TL, Grannemann BD, Chambliss HO, Jordan AN. University of Texas Southwestern Medical Center at Dallas, Mood Disorders Research Program and Clinic, 6363 Forest Park, Dallas, TX 75235, USA. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
The use of augmentation strategies among patients with major depression is increasing because rates of complete remission with standard antidepressant monotherapy are quite low. Clinical and neurobiological data suggest that exercise may be a good candidate for use as an augmentation treatment for depression. This pilot study examined the use of exercise to augment antidepressant medication in patients with major depression. Seventeen patients with incomplete remission of depressive symptoms began a 12-week exercise program while continuing their antidepressant medication (unchanged in type or dose). Individual exercise prescriptions were calculated based on an exercise dose consistent with currently recommended public health guidelines. The exercise consisted of both supervised and home-based sessions. The 17-item Hamilton Rating Scale for Depression (HRSD17) and the Inventory of Depressive Symptomatology-Self-Report (IDS-SR30) were used to assess symptoms of depression on a weekly basis. Intent-to-treat analyses yielded significant decreases on both the HRSD17 (5.8 points, p < 0.008) and IDS-SR30 (13.9 points, p < 0.002). For patients who completed the study (n = 8), HRSD17 scores decreased by 10.4 points and IDS-SR30 scores decreased by 18.8 points. This study provides preliminary evidence for exercise as an effective augmentation treatment for antidepressant medication. This is a lower-cost augmentation strategy that has numerous health benefits and may further reduce depressive symptoms in partial responders to antidepressant treatment. Practical tips on how practitioners can use exercise to enhance antidepressant treatment are discussed. Longer-term use of exercise is also likely to confer additional health benefits for this population.
PMID: 16883145 [PubMed - in process]
Set as favorite
Email This
Hits: 900 Comments (0)
![]() Write comment
Discuss this article on the forums. (0 posts) |
|
| < Prev | Next > |
|---|
Get high quality, great value nutritional supplements & natural personal care products from:
$5 off your first order with our discount code: MAT856
| Nickel sulfide sunnye 03-22-10 02:27 |
| Working with MCS?? dwise21 03-13-10 06:51 |
| MCS safe sunblock?? dwise21 03-12-10 08:40 |
| Phase 11 liver toxicity + MCS SandyJo 03-11-10 22:18 |
| DHEA Supplements Lynn 03-07-10 14:47 |
Subscribe to our newsletter and receive regular updates of our latest content: